The metabolic stone evaluation: An opportunity for shared decision-making


  • Darren Beiko Queen's University



kidney stone, metabolic evaluation, shared decision-making


N/A (it's an editorial/commentary on another paper)


Download data is not yet available.

Author Biography

Darren Beiko, Queen's University

Associate Professor, Department of Urology, Queen's University


Harmouch SS, Abou-Haidar H, Elhawary H, et al. Metabolic evaluation guidelines in patients with nephrolithiasis: Are they being followed? Results of a national, multi-institutional quality assessment study. Can Urol Assoc J 2018 May 28. doi: 10.5489/cuaj.5155. [Epub ahead of print]

Dion M, Ankawi G, Chew B, et al. CUA guideline on the evaluation and medical management of the kidney stone patient – 2016 update. Can Urol Assoc J 2016. 10: p. E347-E358.

Rule AD, Lieske JC, Li X, et al. The ROKS nomogram for predicting a second symptomatic stone episode. J Am Soc Nephrol 2014 Dec;25(12):2878-86. doi: 10.1681/ASN.2013091011. Epub 2014 Aug 7.

Pearle MS, Calhoun EA, Curhan GC. Urologic diseases in America project: urolithiasis. J Urol 2005;173:848-57.

Bensalah K, Tuncel A, Gupta A, et al. Determinants of quality of life for patients with kidney stones. J Urol 2008 Jun;179(6):2238-43; discussion 2243. doi: 10.1016/j.juro.2008.01.116. Epub 2008 Apr 18.

Patel N, Brown RD, Sarkissian C, et al. Quality of life and urolithiasis: the patient - reported outcomes measurement information system (PROMIS). Int Braz J Urol 2017 Sep-Oct;43(5):880-886. doi: 10.1590/S1677-5538.IBJU.2016.0649.

Raffin EP, Penniston KL, Antonelli JA, et al. The effect of thiazide and potassium citrate use on the health-related quality of life of patients with urolithiasis. J Urol 2018 Jun 15. pii: S0022-5347(18)43402-7. doi: 10.1016/j.juro.2018.06.023. [Epub ahead of print]

Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 1996 Mar;155(3):839-43.

Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002 Jan 10;346(2):77-84.

Barcelo P, Wuhl O, Servitge E, et al: Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis. J Urol 1993; 150: 1761.

Pearle MS, Roehrborn CG, Pak CY: Meta-analysis of randomized trials for medical prevention of calcium oxalate nephrolithiasis. J Endourol 1999;13:679-85.

Ettinger B, Tang A, Citron JT, et al. Randomized trial of allopurinol in the prevention of calcium oxalate calculi. N Engl J Med 1986 Nov 27;315(22):1386-9.

Bensalah K, Tuncel A, Raman JD, et al. How physician and patient perceptions differ regarding medical management of stone disease. J Urol 2009 Sep;182(3):998-1004. doi: 10.1016/j.juro.2009.05.025. Epub 2009 Jul 18.

Matlaga BR. Are we correctly managing urinary calculi? J Urol 2009 Sep;182(3):826-7. doi: 10.1016/j.juro.2009.06.072. Epub 2009 Jul 17.




How to Cite

Beiko, D. (2018). The metabolic stone evaluation: An opportunity for shared decision-making. Canadian Urological Association Journal, 12(10).